Latest Shareholder Approval News

Clean Seas Seafood updates shareholders on a revised equity conversion ratio for the Yumbah scrip alternative following significant impairment charges by Yumbah Aquaculture. The scheme meeting is now set for 8 July 2025.

NEXION Group has issued 800,000 convertible notes to raise $80,000, aiming to fund costs related to a proposed acquisition. The notes carry a 10% interest rate and may be repaid in cash or converted into shares and options, pending shareholder approval.

Carbine Resources has successfully raised $1.78 million through a pro-rata entitlement offer and shortfall placement, setting the stage for further shareholder approval in August.

Simble Solutions Limited has secured $527,375 through a strategic capital raising and appointed Faldi Ismail as its new Non-Executive Chairman, signaling a renewed focus on growth and innovation including blockchain investments.

Mayne Pharma shareholders have overwhelmingly approved a scheme for Cosette Pharmaceuticals to acquire the company, setting the stage for a pivotal court hearing later this year.

Codeifai Limited has agreed to acquire its main competitor Trust Codes Global Limited, significantly expanding its footprint and product capabilities ahead of the 2027 global shift to 2D barcodes.

Krakatoa Resources secures $1.3 million via placement to fund a maiden diamond drilling campaign at its Zopkhito Project in Georgia, aiming to upgrade foreign resource estimates to JORC standards.

Blaze Minerals has inked a binding deal to acquire a major interest in the Loulombo Base Metals Project in the Republic of Congo, backed by a $2.52 million capital raise to fund exploration and development.

Emyria has landed a multi-year funding deal with Medibank to support its Empax PTSD program at Perth Clinic, marking a first for private insurer-backed psychotherapy in Australia. The company also announces a $4 million capital raise to fuel national expansion.

X2M Connect Limited has secured $1.95 million through a share placement and convertible note conversion, aiming to strengthen its balance sheet and accelerate growth in AI and IoT sectors.

Mayne Pharma shareholders have overwhelmingly approved the scheme of arrangement for Cosette Pharmaceuticals to acquire the company at $7.40 per share, despite ongoing legal challenges and regulatory approvals still pending.

First Au Limited has successfully raised $1.5 million through a private placement, exceeding its initial target, to fund its strategic acquisition of the Nimba Gold Project in Liberia.